Feb 1 |
Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research
|
Jan 31 |
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
|
Jan 26 |
Windtree Therapeutics (NASDAQ:WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
|
Jan 25 |
Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company
|
Jan 18 |
Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China
|
Jan 17 |
Windtree Therapeutics Announces License Agreement with Lee’s Pharmaceuticals to Develop and Commercialize Istaroxime, Dual Mechanism SERCA2a Activators and Rostafuroxin for Greater China / Asia Pacific Region
|